All News

The FDA has approved a supplemental new drug application for lorlatinib (Lorbrena) to expand the indication to include the frontline treatment of patients with ALK-positive non–small cell lung cancer.

Pharmacy Times® interviewed Sarah Browne, MD, senior director of vaccine development at Altimmune, on the commencement of a phase 1 clinical trial of a single-dose, intranasal COVID-19 vaccine.

In Vienna in the 1770s, a young physician named Franz Friedrich Anton Mesmer happened to meet a Jesuit priest named Maximilian Hell who was conducting medical experiments on patients with rheumatism.

Third party payers have concluded that the fee-for-service system is no longer financially viable and that a new approach is necessary.

Many rural areas identify with many barriers in their community, such as transportation, technology access, human factors, and the design of the health care model.

Recent data have shown alarmingly low rates of human papillomavirus (HPV) vaccine completion among children between 10 and 13 years of age.

Cognitive impairment includes memory and thinking problems that affect concentration, decision making and learning new things, which increases as people grow older.

The study found patients who used mHealth applications had better health outcomes and were able to regulate their health behavior more effectively than patients who did not use these apps, in addition to fewer hospital visits and lower medical costs.

Social media has developed into a powerful and versatile device that can inform and reach a multitude of persons almost instantaneously.

The first vaccine dose alone offered strong protection against COVID-19, with efficacy that did not decline over the 3 months between doses.

Training gives pharmacy staff the tools needed to initiate uncomfortable conversations about mental health and substance use issues.

Paul Ament, PharmD, reviews the guidelines for the treatment of VTE.

ACIP issued an interim recommendation to the Janssen COVID-19 vaccine for use in individuals aged ≥18 years for the prevention of COVID-19.

President Joseph Biden announced a partnership between Merck and Johnson & Johnson, in which 2 of Merck’s facilities will begin producing the Johnson & Johnson COVID-19 vaccine.

The availability of both intravenous and subcutaneous routes of immunoglobulin has made personalization of treatment more important than ever.

Throughout the COVID-19 pandemic, patients hospitalized with the disease have had more to face than just the fight against COVID-19, as co-infection with drug-resistant pathogens has been shown to also contribute to rates of mortality and readmission.

Among the health care professionals staking their ground on social media are a growing list of pharmacists and pharmacy students.

Eating a low-quality diet high in foods and food components associated with chronic inflammation during pregnancy may be associated with an increased risk of obesity and excess body fat in children, especially during late childhood.

COVID-19 is fueling the expansion of treatment methods beyond medications to include digital therapeutics.

A recent study found that a combination of robust vaccination programs and strict physical distancing rules may be effective in the prevention of future COVID-19 infection surges.

Insight on direct coaching and implementation support for new pharmacy business initiatives.